StockData
Biohaven Ltd. logo

Biohaven Ltd. (BHVN) income statement

BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 1/30
$12.39−1.26 (-9.23%)

Close on Nov 20, 2026Market cap $1.87BP/E –Yield –

Biohaven Ltd. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-310.8%

Financial strength

Current ratio
3.05
Debt to equity
-2.69
Debt to assets
100.2%
Cash to current liabilities
152.6%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?